Background Although the etiology of the depigmentation disorder vitiligo is
still not completely understood, many investigators believe that an autoim
mune reaction may play a major role. In this regard, T-lymphocyte-mediated
immunity has been implicated frequently in the pathogenesis of the disease.
Most studies have applied in vitro testing of cell-mediated immunity, howe
ver, rather than in vivo measurements. Therefore, our study was undertaken
to define the cutaneous delayed-type hypersensitivity (DTH) in vivo reactio
n in association with the absence/presence of serum thyroid autoantibodies,
which are a good representative marker for autoimmunity in patients with v
itiligo,
Methods DTH was evaluated in the normal pigmented skin of 109 vitiligo pati
ents (29 men and 80 women) and in the depigmented skin of 27 of this group
(5 men and 22 women) using the dermal application of seven common recall an
tigens together with a negative control. Individuals were considered to be
hypoergic if the DTH sum score was less than or equal to 5 mm in women or l
ess than or equal to 10 mm in men, or ii they responded to only one or two
antigens.
Results The mean sum score was 10.2 +/- 8.4 with an average of 2.3 +/- 1.6
positive reactions in depigmented skin vs. a sum score of 12.4 +/- 9.0 with
an average number of 2.6 +/- 1.6 positive reactions in normal pigmented sk
in. There was no statistically significant difference between depigmented a
nd normal pigmented skin using the paired t-test (P > 0.05). Further evalua
tion of these data showed no significant correlation between the presence o
f thyroid autoantibodies as well as selected clinical parameters and an abe
rration in cutaneous DTH
Conclusions In contrast to earlier reports, our in vivo studies of cutaneou
s DTH reactions revealed no clinically significant aberrant cellular immuni
ty in this patient group. These results indicate that the immune reaction i
n vitiligo may be only a secondary event in the pathogenesis of the disease
.